Wallace D. J. (2008). Improving the prognosis of SLE without prescribing lupus drugs and the primary care paradox. Lupus, 17(2), 91–92.
Bertsias, G., Ioannidis, J. P., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., Isenberg, D., Kallenberg, C. G., Khamashta, M., Piette, J. C., Schneider, M., Smolen, J., Sturfelt, G., Tincani, A., van Vollenhoven, R., Gordon, C., … Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (2008). EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Annals of the rheumatic diseases, 67(2), 195–205.
Jolly M. (2010). Pitfalls and opportunities in measuring patient outcomes in lupus. Current rheumatology reports, 12(4), 229–236.